BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37561777)

  • 1. Plasma metabolomics profiling identifies new predictive biomarkers for disease severity in COVID-19 patients.
    Soares NC; Hussein A; Muhammad JS; Semreen MH; ElGhazali G; Hamad M
    PLoS One; 2023; 18(8):e0289738. PubMed ID: 37561777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted metabolomics identifies high performing diagnostic and prognostic biomarkers for COVID-19.
    López-Hernández Y; Monárrez-Espino J; Oostdam AH; Delgado JEC; Zhang L; Zheng J; Valdez JJO; Mandal R; González FLO; Moreno JCB; Trejo-Medinilla FM; López JA; Moreno JAE; Wishart DS
    Sci Rep; 2021 Jul; 11(1):14732. PubMed ID: 34282210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal metabolomics of human plasma reveals prognostic markers of COVID-19 disease severity.
    Sindelar M; Stancliffe E; Schwaiger-Haber M; Anbukumar DS; Adkins-Travis K; Goss CW; O'Halloran JA; Mudd PA; Liu WC; Albrecht RA; García-Sastre A; Shriver LP; Patti GJ
    Cell Rep Med; 2021 Aug; 2(8):100369. PubMed ID: 34308390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a multiomics model for identification of predictive biomarkers for COVID-19 severity: a retrospective cohort study.
    Byeon SK; Madugundu AK; Garapati K; Ramarajan MG; Saraswat M; Kumar-M P; Hughes T; Shah R; Patnaik MM; Chia N; Ashrafzadeh-Kian S; Yao JD; Pritt BS; Cattaneo R; Salama ME; Zenka RM; Kipp BR; Grebe SKG; Singh RJ; Sadighi Akha AA; Algeciras-Schimnich A; Dasari S; Olson JE; Walsh JR; Venkatakrishnan AJ; Jenkinson G; O'Horo JC; Badley AD; Pandey A
    Lancet Digit Health; 2022 Sep; 4(9):e632-e645. PubMed ID: 35835712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The study of serum hsCRP, ferritin, IL-6 and plasma D-dimer in COVID-19: a retrospective study.
    Ahirwar AK; Takhelmayum R; Sakarde A; Rathod BD; Jha PK; Kumawat R; Gopal N
    Horm Mol Biol Clin Investig; 2022 Sep; 43(3):337-344. PubMed ID: 35357792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A meta-analysis of SARS-CoV-2 patients identifies the combinatorial significance of D-dimer, C-reactive protein, lymphocyte, and neutrophil values as a predictor of disease severity.
    Singh K; Mittal S; Gollapudi S; Butzmann A; Kumar J; Ohgami RS
    Int J Lab Hematol; 2021 Apr; 43(2):324-328. PubMed ID: 33010111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of lab score system for predicting COVID-19 patient severity: A retrospective analysis.
    Sarkar A; Sanyal S; Majumdar A; Tewari DN; Bhattacharjee U; Pal J; Chakrabarti AK; Dutta S
    PLoS One; 2022; 17(9):e0273006. PubMed ID: 36084080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil to lymphocytic ratio and other inflammatory markers as adverse outcome predictor in hospitalized COVID-19 patients.
    Abdelhady SA; Rageh F; Ahmed SS; Al-Touny SA; Riad E; Elhoseeny MM; Khalifa AA; Salim A; Farghly MI; Elgamal R
    Egypt J Immunol; 2022 Apr; 29(2):57-67. PubMed ID: 35436055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D-dimer as a biomarker for assessment of COVID-19 prognosis: D-dimer levels on admission and its role in predicting disease outcome in hospitalized patients with COVID-19.
    Poudel A; Poudel Y; Adhikari A; Aryal BB; Dangol D; Bajracharya T; Maharjan A; Gautam R
    PLoS One; 2021; 16(8):e0256744. PubMed ID: 34437642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of COVID-19 severity using laboratory findings on admission: informative values, thresholds, ML model performance.
    Statsenko Y; Al Zahmi F; Habuza T; Gorkom KN; Zaki N
    BMJ Open; 2021 Feb; 11(2):e044500. PubMed ID: 33637550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calculated plasma osmolality at hospital admission correlates well with eGFR and D-Dimer, a simple outcome predictor and guiding tool for management of severe COVID-19 patients.
    Ramesh J; Rajesh M; Varghese J; Reddy SLS
    Diabetes Metab Syndr; 2021; 15(5):102240. PubMed ID: 34403950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma metabolomic profiling in patients with rheumatoid arthritis identifies biochemical features predictive of quantitative disease activity.
    Hur B; Gupta VK; Huang H; Wright KA; Warrington KJ; Taneja V; Davis JM; Sung J
    Arthritis Res Ther; 2021 Jun; 23(1):164. PubMed ID: 34103083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of laboratory parameters in predicting severity of COVID-19 disease in pregnant patients.
    Sahin O; Aktoz F; Bagci H; Vurgun E
    J Obstet Gynaecol; 2022 Aug; 42(6):1917-1921. PubMed ID: 35603633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic changes of D-dimer and neutrophil-lymphocyte count ratio as prognostic biomarkers in COVID-19.
    Ye W; Chen G; Li X; Lan X; Ji C; Hou M; Zhang D; Zeng G; Wang Y; Xu C; Lu W; Cui R; Cai Y; Huang H; Yang L
    Respir Res; 2020 Jul; 21(1):169. PubMed ID: 32620118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D-Dimer as a potential biomarker for disease severity in COVID-19.
    Ozen M; Yilmaz A; Cakmak V; Beyoglu R; Oskay A; Seyit M; Senol H
    Am J Emerg Med; 2021 Feb; 40():55-59. PubMed ID: 33348224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality in Patients of COVID-19 Infection: Biochemical Markers and its Cut-off Values for Predicting Outcome.
    Yousaf MN; Sarwar S; Tarique S; Ahmed M; Tahir H
    J Coll Physicians Surg Pak; 2022 Jan; 32(1):37-41. PubMed ID: 34983145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic markers of both severity and outcome.
    Roberts I; Wright Muelas M; Taylor JM; Davison AS; Xu Y; Grixti JM; Gotts N; Sorokin A; Goodacre R; Kell DB
    Metabolomics; 2021 Dec; 18(1):6. PubMed ID: 34928464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of simple and cost-effective immuno- haematological markers to predict outcome in hospitalized severe COVID-19 patients, with a focus on diabetes mellitus - A retrospective study in Andhra Pradesh, India.
    Ramesh J; Reddy SLS; Rajesh M; Varghese J
    Diabetes Metab Syndr; 2021; 15(3):739-745. PubMed ID: 33819728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum biomarker panel for disease severity and prognosis in patients with COVID-19.
    Li J; Tang M; Liu D; Xie Z; Wang F; Yang Y
    J Clin Lab Anal; 2023 Jan; 37(2):e24831. PubMed ID: 36604799
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.